VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_17-vv-01310
Package ID: USCOURTS-cofc-1_17-vv-01310
Petitioner: Rodolfo Monterroso
Filed: 2017-09-22
Decided: 2019-05-29
Vaccine: influenza
Vaccination date: 2016-10-06
Condition: Guillain-Barré syndrome
Outcome: compensated
Award amount USD: 85000

AI-assisted case summary:
On September 22, 2017, Rodolfo Monterroso filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he suffered Guillain-Barré syndrome (GBS) as a result of receiving an influenza vaccine and a tetanus-diphtheria-acellular pertussis (Tdap) vaccine on October 6, 2016. The respondent, the Secretary of Health and Human Services, denied that the vaccines caused the alleged injuries. However, the parties reached a stipulation for an award. The decision notes that both the influenza and Tdap vaccines are listed on the Vaccine Injury Table. The stipulation awarded Rodolfo Monterroso a lump sum of $85,000.00 as compensation for all damages. Special Master Thomas L. Gowen adopted the parties' stipulation. The decision was entered on May 29, 2019. Petitioner counsel was Danielle A. Strait of Maglio, Christopher & Toale. Respondent counsel was Jay M. All of the U.S. Department of Justice. The public decision does not describe the onset of symptoms, specific clinical details, medical tests, or treatments. The specific mechanism of causation was not detailed in the public decision.

Theory of causation field:
Petitioner Rodolfo Monterroso received an influenza and Tdap vaccine on October 6, 2016, and subsequently alleged Guillain-Barré syndrome (GBS). The respondent denied causation. The case was settled via stipulation for an award of $85,000.00. Both the influenza and Tdap vaccines are listed on the Vaccine Injury Table, supporting a potential "Table" theory of causation. No specific medical experts or detailed causation theories were presented in the public decision text. The public decision does not describe the onset, symptoms, diagnostic tests, or treatments for the alleged GBS. The Special Master adopted the parties' stipulation. The decision date was May 29, 2019. Petitioner counsel was Danielle A. Strait, and respondent counsel was Jay M. All. Special Master was Thomas L. Gowen.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_17-vv-01310-0
Date issued/filed: 2019-06-24
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 05/29/2019) regarding 42 DECISION Stipulation/Proffer, Signed by Special Master Thomas L. Gowen. (hs) Service on parties made.
--------------------------------------------------------------------------------
Case 1:17-vv-01310-UNJ Document 46 Filed 06/24/19 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: May 29, 2019
* * * * * * * * * * * * *
RODOLFO MONTERROSO, * UNPUBLISHED
*
Petitioner, * No.17-1310V
*
v. * Special Master Gowen
*
SECRETARY OF HEALTH * Stipulation for Award;
AND HUMAN SERVICES, * Influenza (“flu”); Guillain-Barré
* Syndrome (“GBS”); Tetanus-
Respondent. * Diphtheria-acellular pertussis
* * * * * * * * * * * * * (“Tdap”).
Danielle A. Strait, Maglio, Christopher & Toale (WA), Seattle, WA, for petitioner.
Jay M. All, U.S. Department of Justice, Washington, D.C., for respondent.
DECISION FOR STIPULATION1
On September 22, 2017, Rodolfo Monterroso (“petitioner”) filed a petition for
compensation under the National Vaccine Injury Compensation Program.2 Petition at Preamble.
Petitioner received an influenza (“flu”) vaccine and a tetanus-diphtheria-acellular pertussis
(“Tdap”) vaccine on October 6, 2016. Id. at 1; Stipulation at ¶ 2 (ECF No. 41). Petitioner
alleged that as a result of receiving the vaccinations he suffered Guillain-Barré syndrome
(“GBS”). Petition at ¶ 4; Stipulation at ¶ 4.
On May 28, 2019, respondent filed a stipulation providing that a decision should be
entered awarding compensation to petitioner. Stipulation at ¶ 7. Respondent denies that
petitioner’s alleged injuries are caused by the vaccines. Id. at ¶ 6. Maintaining their respective
1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this opinion contains a
reasoned explanation for the action in this case, I am required to post it on the website of the United States Court of
Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. This means the
opinion will be available to anyone with access to the Internet. Before the opinion is posted on the court’s
website, each party has 14 days to file a motion requesting redaction “of any information furnished by that party:
(1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that
includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of
privacy.” Vaccine Rule 18(b). “An objecting party must provide the court with a proposed redacted version of the
decision.” Id. If neither party files a motion for redaction within 14 days, the opinion will be posted on the
court’s website without any changes. Id.
2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine
Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012)
(Vaccine Act or the Act). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. §
300aa.

Case 1:17-vv-01310-UNJ Document 46 Filed 06/24/19 Page 2 of 7
positions, the parities nevertheless now agree that the issues between them shall be settled and
that a decision should be entered awarding compensation to petitioner according to the terms of
the stipulation attached hereto as Appendix A. Id. at ¶ 7.
The stipulation awards:
1) A lump sum of $85,000.00, in the form of a check payable to petitioner, which
amount represents compensation for all damages available under 42 U.S.C. §
300aa-15(a).
I adopt the parties’ stipulation attached hereto, and award compensation in the amount
and on the terms set forth therein. The Clerk of the Court SHALL ENTER JUDGMENT in
accordance with the terms of the parties’ stipulation.3
IT IS SO ORDERED.
s/Thomas L. Gowen
Thomas L. Gowen
Special Master
3 Entry of judgment is expedited by each party’s filing notice renouncing the right to seek review. Vaccine Rule
11(a).
2

Case 1:17-vv-01310-UNJ Document 46 Filed 06/24/19 Page 3 of 7
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
)
RODOLFO MONTERROSO, )
)
Petitioner, )
) No. 17-1310V
v. ) Special Master Gowen
) ECF
SECRETARY OF HEALTH AND HUMAN )
SERVICES, )
)
Respondent. )
)
)
)
STIPULATION
The parties hereby stipulate to the following matters:
1. Rodolfo Monterroso, petitioner, filed a petition for vaccine compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 to -34 (the “Vaccine
Program”). The petition seeks compensation for injuries allegedly related to petitioner’s receipt
of the influenza (“flu”) and/or tetanus-diphtheria-acellular pertussis (“Tdap”) vaccines, which
vaccines are contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. § 100.3(a).
2. Petitioner received the vaccines on October 6, 2016.
3. The vaccines were administered within the United States.
4. Petitioner alleges that he suffered Guillain-Barré Syndrome (“GBS”) as the result of
the vaccines and that he experienced the residual effects of this condition for more than six
months.
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages on his behalf as a result of his alleged injuries.

Case 1:17-vv-01310-UNJ Document 46 Filed 06/24/19 Page 4 of 7
6. Respondent denies that the vaccines are the cause of petitioner’s alleged GBS or any
other injury or condition.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entry of judgment reflecting a decision consistent with
the terms of this Stipulation, and after petitioner has filed an election to receive compensation
pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue
the following vaccine compensation payment:
A lump sum of $85,000.00, in the form of a check payable to petitioner. This
amount represents compensation for all damages that would be available under 42
U.S.C. § 300aa-15(a).
9. As soon as practicable after the entry of judgment on entitlement in this case, and after
petitioner has filed both a proper and timely election to receive compensation pursuant to 42
U.S.C. § 300aa-21(a)(1), and an application, the parties will submit to further proceedings before
the special master to award reasonable attorneys’ fees and costs incurred in proceeding upon this
petition.
10. Petitioner and his attorney represent that compensation to be provided pursuant to
this Stipulation is not for any items or services for which the Program is not primarily liable
under 42 U.S.C. § 300aa-15(g), to the extent that payment has been made or can reasonably be
expected to be made under any State compensation programs, insurance policies, Federal or
State health benefits programs (other than Title XIX of the Social Security Act (42 U.S.C.
§ 1396 et seq.)), or by entities that provide health services on a pre-paid basis.
2

Case 1:17-vv-01310-UNJ Document 46 Filed 06/24/19 Page 5 of 7
11. Payment made pursuant to paragraph 8 of this Stipulation, and any amounts awarded
pursuant to paragraph 9 of this Stipulation, will be made in accordance with 42 U.S.C. § 300aa-
15(i), subject to the availability of sufficient statutory funds.
12. The parties and their attorneys further agree and stipulate that, except for any award
for attorneys’ fees and litigation costs, the money provided pursuant to this Stipulation will be
used solely for the benefit of petitioner, as contemplated by a strict construction of 42 U.S.C.
§ 300aa-15(a) and (d), and subject to the conditions of 42 U.S.C. §§ 300aa-15(g) and (h).
13. In return for the payments described in paragraphs 8 and 9, petitioner, in his
individual capacity and on behalf of his heirs, executors, administrators, successors or assigns,
does forever irrevocably and unconditionally release, acquit and discharge the United States and
the Secretary of Health and Human Services from any and all actions, causes of action (including
agreements, judgments, claims, damages, loss of services, expenses and all demands of whatever
kind or nature) that have been brought, could have been brought, or could be timely brought in
the Court of Federal Claims, under the National Vaccine Injury Compensation Program, 42
U.S.C. § 300aa-10 et seq., on account of, or in any way growing out of, any and all known or
unknown, suspected or unsuspected personal injuries to or death of petitioner resulting from, or
alleged to have resulted from, the vaccines administered on or about October 6, 2016, as alleged
by petitioner in a petition for vaccine compensation filed on September 22, 2017, in the United
States Court of Federal Claims as petition No. 17-1310V.
14. If petitioner should die prior to entry of judgment, this agreement shall be voidable
upon proper notice to the Court on behalf of either or both of the parties.
15. If the special master fails to issue a decision in complete conformity with the terms
of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a
3

Case 1:17-vv-01310-UNJ Document 46 Filed 06/24/19 Page 6 of 7
decision that is in complete conformity with the terms of this Stipulation, then the parties’
settlement and this Stipulation shall be voidable at the sole discretion of either party.
16. This Stipulation expresses a full and complete negotiated settlement of liability and
damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except
as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the
parties hereto to make any payment or to do any act or thing other than is herein expressly stated
and clearly agreed to. The parties further agree and understand that the award described in this
stipulation may reflect a compromise of the parties’ respective positions as to liability and/or
amount of damages, and further, that a change in the nature of the injury or condition or in the
items of compensation sought, is not grounds to modify or revise this agreement.
17. This Stipulation shall not be construed as an admission by the United States or the
Secretary of Health and Human Services that either the flu or Tdap vaccines caused petitioner’s
alleged injuries or any other injury or his current condition.
18. All rights and obligations of petitioner hereunder shall apply equally to petitioner’s
heirs, executors, administrators, successors, and/or assigns.
END OF STIPULATION
4

Case 1:17-vv-01310-UNJ Document 46 Filed 06/24/19 Page 7 of 7